TY - JOUR
T1 - The potential role of abnormal E-cadherin and α-, β- and γ-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma
AU - Papadavid, Evangelia
AU - Pignatelli, M.
AU - Zakynthinos, S.
AU - Krausz, T.
AU - Chu, A. C.
PY - 2001
Y1 - 2001
N2 - Background: Failure of E-cadherin and its associated proteins α-, β- and γ-catenin is believed to lead to disruption of cell-cell adhesion and to contribute to neoplasia. Objectives: To determine the pattern of E-cadherin and α-, β- and γ-catenin immunostaining in keratoacanthoma (KA) and to evaluate its potential value in routine histopathology in differentiating KA with benign from that with malignant biological behaviour. Methods: We examined the expression of E-cadherin and α-, β- and γ-catenin in KA and correlated the histopathological features with the immunohistochemical findings. Next, we compared the immunohistochemical findings of KA with those found in malignant (squamous cell carcinoma, SCC) and benign (warts) lesions. In addition to the established histopathological criteria we used the Ki-67 index, a well-known marker of cell proliferation, Immnunoperoxidase staining of E-cadherin and α-, β- and γ-catenin, and Ki-67 determination, were performed in paraffin-embedded sections of 12 KAs taken from archival material. On reviewing the histology, seven of the 12 KAs were characterized as 'classical' KA. and the rest as 'borderline' KA or KA resembling SCC. Additionally, 28 well, nine moderately and five poorly differentiated SCCs and 20 warts were examined. Results: Most 'classical' KAs (79-86%) showed normal membranous immunostaining and a low Ki-67 index. The remaining 'classical' KAs showed abnormal expression, in a staining pattern resembling that of well-differentiated SCC. All 'borderline' KAs showed a high Ki-67 index (> 40%) and abnormal expression of the adhesion molecules studied, identical to that of poorly differentiated SCC. Expression of E-cadherin and α-, β- and γ-catenin was found to be more frequently abnormal in 'borderline' KA compared with that in 'classical' KA (P < 0.05). Among E-cadherin and α-, β- and γ-catenin expression and Ki-67 index, only the expression of β-catenin was more frequently found to be abnormal in total SCC than in total KA (P < 0.05). Expression of E-cadherin and α-, β- and γ-catenin was more frequently found to be abnormal in well-differentiated SCC than in 'classical' KA (P < 0.05). In total, as well as in 'classical' or 'borderline' KA, an agreement between expression of E-cadherin and of catenins was seen. Conclusions: These findings suggest that E-cadherin and catenins may be very helpful in distinguishing between 'classical' and 'borderline' KA, as the expression of these adhesion molecules in 'classical' KA is identical to that found in normal epidermis, overlapping with well-differentiated SCC in some cases. In 'borderline' KA, expression of adhesion molecules is identical to that in poorly differentiated SCC.
AB - Background: Failure of E-cadherin and its associated proteins α-, β- and γ-catenin is believed to lead to disruption of cell-cell adhesion and to contribute to neoplasia. Objectives: To determine the pattern of E-cadherin and α-, β- and γ-catenin immunostaining in keratoacanthoma (KA) and to evaluate its potential value in routine histopathology in differentiating KA with benign from that with malignant biological behaviour. Methods: We examined the expression of E-cadherin and α-, β- and γ-catenin in KA and correlated the histopathological features with the immunohistochemical findings. Next, we compared the immunohistochemical findings of KA with those found in malignant (squamous cell carcinoma, SCC) and benign (warts) lesions. In addition to the established histopathological criteria we used the Ki-67 index, a well-known marker of cell proliferation, Immnunoperoxidase staining of E-cadherin and α-, β- and γ-catenin, and Ki-67 determination, were performed in paraffin-embedded sections of 12 KAs taken from archival material. On reviewing the histology, seven of the 12 KAs were characterized as 'classical' KA. and the rest as 'borderline' KA or KA resembling SCC. Additionally, 28 well, nine moderately and five poorly differentiated SCCs and 20 warts were examined. Results: Most 'classical' KAs (79-86%) showed normal membranous immunostaining and a low Ki-67 index. The remaining 'classical' KAs showed abnormal expression, in a staining pattern resembling that of well-differentiated SCC. All 'borderline' KAs showed a high Ki-67 index (> 40%) and abnormal expression of the adhesion molecules studied, identical to that of poorly differentiated SCC. Expression of E-cadherin and α-, β- and γ-catenin was found to be more frequently abnormal in 'borderline' KA compared with that in 'classical' KA (P < 0.05). Among E-cadherin and α-, β- and γ-catenin expression and Ki-67 index, only the expression of β-catenin was more frequently found to be abnormal in total SCC than in total KA (P < 0.05). Expression of E-cadherin and α-, β- and γ-catenin was more frequently found to be abnormal in well-differentiated SCC than in 'classical' KA (P < 0.05). In total, as well as in 'classical' or 'borderline' KA, an agreement between expression of E-cadherin and of catenins was seen. Conclusions: These findings suggest that E-cadherin and catenins may be very helpful in distinguishing between 'classical' and 'borderline' KA, as the expression of these adhesion molecules in 'classical' KA is identical to that found in normal epidermis, overlapping with well-differentiated SCC in some cases. In 'borderline' KA, expression of adhesion molecules is identical to that in poorly differentiated SCC.
KW - Immunohistochemistry
KW - Keratoacanthoma
KW - Squamous cell carcinoma
KW - α-catenin
KW - β-cadherin
KW - β-catenin
KW - γ-catenin
UR - http://www.scopus.com/inward/record.url?scp=0035788743&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035788743&partnerID=8YFLogxK
U2 - 10.1046/j.1365-2133.2001.04459.x
DO - 10.1046/j.1365-2133.2001.04459.x
M3 - Article
C2 - 11703284
AN - SCOPUS:0035788743
SN - 0007-0963
VL - 145
SP - 582
EP - 589
JO - British Journal of Dermatology
JF - British Journal of Dermatology
IS - 4
ER -